Skip to main content

Lipocine Inc.

corporate_fare Company Profile

Lipocine Inc.

Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders. Its lead product candidate is TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. The company's pipeline candidates also include LPCN 1111 (TLANDO XR), a next-generation long-acting oral product candidate for TRT; LPCN 1148, a novel prodrug of testosterone and testosterone laurate for the treatment of cirrhosis; LPCN 1154 to treat postpartum depression; LPCN 2101, a NAS candidate for women with epilepsy; and LPCN 2203, an oral candidate for management of essential tremor. It also develops LPCN 1144, an oral prodrug of bioidentical testosterone for the treatment of metabolic dysfunction-associated steatohepatitis; LPCN 2401 to improve body composition in obesity management; and LPCN 1107, an oral hydroxy progesterone caproate product indicated for the prevention of recurrent preterm birth. The company was founded in 1997 and is headquartered in Salt Lake City, Utah.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed LPCN - Latest Insights

LPCN
Apr 21, 2026, 5:12 PM EDT
Filing Type: DEFA14A
Importance Score:
7
LPCN
Apr 21, 2026, 5:01 PM EDT
Filing Type: DEF 14A
Importance Score:
8
LPCN
Apr 21, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
LPCN
Apr 07, 2026, 6:27 PM EDT
Filing Type: 4
Importance Score:
8
LPCN
Apr 06, 2026, 7:01 PM EDT
Filing Type: 4
Importance Score:
9
LPCN
Apr 06, 2026, 6:33 PM EDT
Filing Type: 4
Importance Score:
8
LPCN
Apr 02, 2026, 9:40 AM EDT
Filing Type: 8-K
Importance Score:
8
LPCN
Apr 02, 2026, 9:35 AM EDT
Filing Type: 8-K
Importance Score:
9
LPCN
Apr 02, 2026, 8:14 AM EDT
Source: Reuters
Importance Score:
9
LPCN
Mar 10, 2026, 6:13 AM EDT
Filing Type: 8-K
Importance Score:
8
LPCN
Mar 09, 2026, 9:09 PM EDT
Filing Type: 10-K
Importance Score:
8
LPCN
Mar 09, 2026, 8:35 AM EDT
Source: Reuters
Importance Score:
7
LPCN
Feb 26, 2026, 5:50 PM EST
Source: Reuters
Importance Score:
9
LPCN
Feb 26, 2026, 5:33 PM EST
Filing Type: 424B5
Importance Score:
8
LPCN
Feb 18, 2026, 9:37 AM EST
Filing Type: 8-K
Importance Score:
7
LPCN
Feb 18, 2026, 9:35 AM EST
Filing Type: 8-K
Importance Score:
8
LPCN
Jan 20, 2026, 9:31 AM EST
Filing Type: 8-K
Importance Score:
8
LPCN
Jan 12, 2026, 4:25 PM EST
Filing Type: 8-K
Importance Score:
8
LPCN
Jan 12, 2026, 9:30 AM EST
Filing Type: 8-K
Importance Score:
8